Success Metrics

Active Trials
5(71%)

Phase Distribution

Ph phase_2
4
57%
Ph early_phase_1
1
14%
Ph phase_3
1
14%

Phase Distribution

1

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
4(66.7%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

7

all time

Status Distribution
Active(7)

Detailed Status

Recruiting5
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
5
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (16.7%)
Phase 24 (66.7%)
Phase 31 (16.7%)

Trials by Status

recruiting571%
not_yet_recruiting229%

Recent Activity

5 active trials
Showing 5 of 7
recruitingphase_3

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

NCT07613099
recruitingearly_phase_1

Fibroblast Activating Protein (FAP) PET/CT in Adults With Tuberculosis

NCT07830771
recruitingphase_2

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT06503146
not_yet_recruitingphase_2

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

NCT07285993
recruiting

18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients

NCT07077213
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07613099Phase 3

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

Recruiting
NCT07830771Early Phase 1

Fibroblast Activating Protein (FAP) PET/CT in Adults With Tuberculosis

Recruiting
NCT06503146Phase 2

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Recruiting
NCT07285993Phase 2

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

Not Yet Recruiting
NCT07077213

18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients

Recruiting
NCT07018661Phase 2

[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer

Recruiting
NCT06568783Phase 2

Evaluation of Patients With Refractory Dermatomyositis Using [18F] FAPI-74 PET/MRI Imaging

Not Yet Recruiting

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7